Felicia Wells

发表

Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry

A. Dippenaar, Annelies Van Rie, R. Warren, 2024, PloS one.

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial

L. Rigouts, T. Heupink, G. Maartens, 2022, Trials.